<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169577/" ref="ordinalpos=2204&amp;ncbi_uid=6641978&amp;link_uid=PMC4169577" image-link="/pmc/articles/PMC4169577/figure/pone-0107950-g002/" class="imagepopup">Figure 2. Infarct size expressed as a percentage of area at risk, as determined by TTC staining..  From: RISK and SAFE <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> Involvement in Apolipoprotein A-I-Induced Cardioprotection. </a></div><br /><div class="p4l_captionBody">Results are expressed as mean±SEM. Wort: Wortmannin, an inhibitor of PI3 K/Akt pathway; U0126: an inhibitor of the MEK1/2-ERK1/2 pathway; AG490: an inhibitor of the JAK/STAT pathway. *p&lt;0.05 vs. Control, n = 6–8 in each group.</div></div>